Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Discovery Therapeutics reports on WRC-0571

May 3, 1996

ATP-sensitive K channel opener reported by Chinese academics

May 3, 1996

Ajinomoto reports on antihypertensive agent AP-1067

May 3, 1996

More research into angiotensin II antagonists at Takeda

May 3, 1996

Takeda discovers new PGDF inhibitors

May 3, 1996

NOS inhibitors claimed by Ono

April 26, 1996

Japanese investigators reveal new agent for heart failure

April 26, 1996

BMS-193884 in development for heart failure

April 26, 1996

Class III antiarrhythmic presented by Japanese academics

April 26, 1996

GP-531 enters phase II

April 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 19, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...